ArticleToxics2026
SARS-CoV-2 Anti-Spike IgG Subclass Titres in a Population with Prior Exposure to Perfluorooctanoic Acid (PFOA).
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The role of perfluorooctanoic acid (PFOA) on antibody titres following vaccination in adults is not heterogeneous. High levels of anti-spike IgG have been reported following mRNA-based vaccinations. This study aimed to explore the association between PFOA exposure and exposure to SARS-CoV-2 antigen on SARS-CoV-2 anti-spike antibodies, particularly on the IgG subclasses in adult residents with increased internal PFOA exposure due to past PFOA drinking water contamination. A self-administered questionnaire was completed, and vaccination data was checked against the vaccination passport. PFOA concentration and IgG subclass titres were analysed in serum. Most study participants had three vaccinations (518; 78.6%). IgG was dominated by IgG4, a subclass that is largely unable to activate effector responses, for 8.3% of the participants, and only in the group of participants with three vaccinations. A generalised linear model was used to assess the relationship between PFOA serum concentration and IgG subclasses. After adjusting for age, a significant positive association was found between the number of vaccinations, self-reported infections and higher IgG subclasses concentrations. Age and PFOA concentration did not show a significant association with the concentration of any IgG subclass. Thus, the internal PFOA exposure was not associated with impaired immune response with regard to anti-spike SARS-CoV-2 IgG.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.